Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Lymphoma 2Breast Neoplasms 2Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Pain, Postoperative 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Malignant Neoplasms of Male Genital Organs 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Hairy Cell 1Leukemia 1Hodgkin Disease 1Goiter 1Carcinoma, Small Cell 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Epinephrine × Clear all
NCT02659501 2021-01-12

Liposomal Bupivacaine in Implant Based Breast Reconstruction

Loma Linda University

Phase NA Terminated
24 enrolled 10 charts
Breast

Breast Neoplasms, Pain, Postoperative

NCT02525718 2019-08-14

Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

Northwestern University

Phase 2 Completed
47 enrolled 7 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡